{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:05:12Z","timestamp":1795089912530,"version":"4.10.2"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:p>Distinguishing between uterine neoplasms of smooth muscle and endometrial stromal origin is a frequent diagnostic challenge. We investigated the staining pattern of interferon-induced transmembrane protein-1 (IFITM1), a novel endometrial stromal marker, in endometrial and smooth muscle uterine neoplasms and compared it with CD10 in its ability to differentiate between these two groups. Immunohistochemistry for IFITM1 and CD10 was performed in 20 cases of smooth muscle neoplasms (10 cases leiomyoma, 10 cases leiomyosarcoma), 14 cases of endometrial stromal sarcoma (ESS) (12 cases of low grade and 2 cases of high grade) and 12 cases of carcinosarcoma. Staining was scored in terms of intensity and distribution (0=absent, 1=weak\/&lt;50%, 2=moderate\/50%\u201375%, 3=strong\/&gt;75%). A total score was obtained by adding intensity and distribution scores and classified as positive (score 3\u20136) or negative (score 0\u20132). IFITM1 was positive in 10 of 12 (83%) low-grade ESSs, 6 of 20 (30%) smooth muscle tumors (leiomyomas and leiomyosarcomas) and 11 of 12 carcinosarcomas (91.6%). The 2 cases of high-grade ESS were IFITM1 negative. While both IFITM1 (83%) and CD10 (91%) had high sensitivity in differentiating low-grade ESSs from smooth muscle neoplasms, IFITM1 (70%) had higher specificity compared with CD10 (45%). In this study IFITM1 appears to be a more specific marker of endometrial stromal differentiation compared with CD10 in differentiating low-grade ESSs from smooth muscle neoplasms. Thus, IFITM1 may be a valuable tool as part of an immunohistochemical evaluation panel in this diagnostic scenario.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000424","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T15:02:53Z","timestamp":1499785373000},"page":"372-378","source":"Crossref","is-referenced-by-count":41,"title":["IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus"],"prefix":"10.1097","volume":"37","author":[{"given":"Aurelia","family":"Busca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Previn","family":"Gulavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Parra-Herran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","article-title":"Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients","volume":"54","author":"Abeler","year":"2009","journal-title":"Histopathology"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PGP.0b013e318200caff","article-title":"Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases","volume":"30","author":"Abeler","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004347-200201000-00008","article-title":"CD10 is a marker for normal and neoplastic endometrial stromal cells","volume":"21","author":"Toki","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2559.2001.01215.x","article-title":"CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms","volume":"39","author":"McCluggage","year":"2001","journal-title":"Histopathology"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","article-title":"An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies","volume":"26","author":"Oliva","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/01.MP.0000026058.33869.DB","article-title":"Expression of CD10 in malignant m\u00fcllerian mixed tumors and adenosarcomas: an immunohistochemical study","volume":"15","author":"Mikami","year":"2002","journal-title":"Mod Pathol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D\u2019Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1071\/RD10086","article-title":"Characterisation of mouse interferon-induced transmembrane protein-1 gene expression in the mouse uterus during the oestrous cycle and pregnancy","volume":"23","author":"Park","year":"2011","journal-title":"Reprod Fertil Dev"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/modpathol.2013.123","article-title":"Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics: the IFITM1 model","volume":"27","author":"Parra-Herran","year":"2014","journal-title":"Mod Pathol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ajcp\/aqw021","article-title":"IFITM1 is superior to CD10 as a marker of endometrial stroma in the evaluation of myometrial invasion by endometrioid adenocarcinoma","volume":"145","author":"Busca","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0b013e31824a7b1a","article-title":"The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jcp.55.5.321","article-title":"Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?","volume":"55","author":"McCluggage","year":"2002","journal-title":"J Clin Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004347-199001000-00001","article-title":"Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases","volume":"9","author":"Silverberg","year":"1990","journal-title":"Int J Gynecol Pathol Off"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"e1001258","DOI":"10.1371\/journal.ppat.1001258","article-title":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Pathog"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.onc.1209807","article-title":"IFITM1 plays an essential role in the antiproliferative action of interferon-gamma","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"e44609","DOI":"10.1371\/journal.pone.0044609","article-title":"In vivo functional requirement of the mouse IFITM1 gene for germ cell development, interferon mediated immune response and somitogenesis","volume":"7","author":"Klymiuk","year":"2012","journal-title":"PloS One"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1158\/0008-5472.CAN-05-2731","article-title":"Identification of the IFITM family as a new molecular marker in human colorectal tumors","volume":"66","author":"Andreu","year":"2006","journal-title":"Cancer Res"},{"key":"R19-20230824","first-page":"2599","article-title":"Dissecting Wnt\/beta-catenin signaling during gastrulation using RNA interference in mouse embryos","volume":"132","author":"Lickert","year":"2005","journal-title":"Dev Camb Engl"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajpath.2012.03.027","article-title":"Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism","volume":"181","author":"Lee","year":"2012","journal-title":"Am J Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201807000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:29:11Z","timestamp":1692840551000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201807000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000424","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}